Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Irene Roberts

Emeritus Professor of Paediatric Haematology

  • MRC Investigator, MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine

RESEARCH INTERESTS

I have a longstanding interest in understanding the developmentally-regulated, molecular and biological properties of fetal haematopoietic stem and progenitor cells (HSPC) that underlie the development of blood problems that affect babies and young children.

 

BACKGROUND

Irene Roberts qualified in medicine at Glasgow University, Scotland in 1978. After training in paediatrics and haematology and doctoral training in Garret FitzGerald's lab, Vanderbilt University, Nashville, she joined Lucio Luzzatto's lab at Imperial College London where she established her own group. She moved to the Department of Paediatrics and MRC Molecular Haematology Unit in the Weatherall Institute of Molecular Medicine, University of Oxford, in 2013.

 

OTHER ROLES

I am an Associate Editor of Blood and Vice-chair of the Scientific Committee on Blood Disorders in Childhood of the American Society for Hematology. I am also a member of the European Hematology Association Global Outreach Committee and formerly held senior positions in the Executive Board and a number of other constituted and ad hoc committees. I was previously an Honorary Consultant Paediatric Haematologist at Oxford University Hospitals NHS Trust and Imperial College Healthcare NHS Trust and Theme Lead for the Non-Malignant Haematological Disorders for the National Institute of Health Research (NIHR) Translational Research Collaboration Rare Diseases Collaboration.